Yang X - Search Results

1

[Analysis of differential gel electrophoresis of paclitaxol resistant and sensitive lung adenocarcinoma cells' secretome.].

Sun Q, Yang X, Lu J, Xie Y, Chu T, Sha H. Sun Q, et al. Among authors: yang x. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):735-40. doi: 10.3779/j.issn.1009-3419.2009.07.001. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719147 Free article. Chinese.

2

Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.

Sun QL, Sha HF, Yang XH, Bao GL, Lu J, Xie YY. Sun QL, et al. J Cancer Res Clin Oncol. 2011 Mar;137(3):521-32. doi: 10.1007/s00432-010-0913-9. Epub 2010 May 25. J Cancer Res Clin Oncol. 2011. PMID: 20499251

3

[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].

Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX. Gao ZQ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):284-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20646461 Chinese.

4

[Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage I-II Lung Cancer.].

Wang H, Feng J, Zhang X, Yang X, He W, Sha H, Han B. Wang H, et al. Among authors: yang x. Zhongguo Fei Ai Za Zhi. 2009 May 20;12(5):387-95. doi: 10.3779/j.issn.1009-3419.2009.05.003. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719132 Free article. Chinese.

5

Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.

Sun QL, Fang WT, Feng J, Zhang J, Yang XH, Gu ZT, Zhu L, Sha HF. Sun QL, et al. Chin Med J (Engl). 2012 Aug;125(16):2811-8. Chin Med J (Engl). 2012. PMID: 22932072

6

Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery.

Li C, Shen Y, Hu F, Chu T, Yang X, Shao J, Zheng X, Xu J, Zhang H, Han B, Zhong H, Zhang X. Li C, et al. Among authors: yang x. Lung Cancer. 2020 Mar;141:72-77. doi: 10.1016/j.lungcan.2020.01.007. Epub 2020 Jan 10. Lung Cancer. 2020. PMID: 31955003 Clinical Trial.

7

Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors.

Ku X, Sun Q, Zhu L, Gu Z, Han Y, Xu N, Meng C, Yang X, Yan W, Fang W. Ku X, et al. Among authors: yang x. Mol Oncol. 2020 Apr;14(4):721-741. doi: 10.1002/1878-0261.12642. Epub 2020 Feb 6. Mol Oncol. 2020. PMID: 31967407 Free PMC article.

8

Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery.

Xiong A, Li C, Xu J, Yang X, Nie W, Zhong H, Chu T, Zhang W, Zhong R, Pan F, Shen Y, Lou Y, Zhang B, Han B, Zhang X. Xiong A, et al. Among authors: yang x. Lung Cancer. 2021 Apr;154:124-130. doi: 10.1016/j.lungcan.2021.02.029. Epub 2021 Feb 24. Lung Cancer. 2021. PMID: 33657514

9

hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527.

Li C, Zhang J, Yang X, Hu C, Chu T, Zhong R, Shen Y, Hu F, Pan F, Xu J, Lu J, Zheng X, Zhang H, Nie W, Han B, Zhang X. Li C, et al. Among authors: yang x. Cell Death Dis. 2021 Aug 25;12(9):807. doi: 10.1038/s41419-021-04095-8. Cell Death Dis. 2021. PMID: 34433810 Free PMC article.

10

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer.

Zheng L, Hu F, Huang L, Lu J, Yang X, Xu J, Wang S, Shen Y, Zhong R, Chu T, Zhang W, Li Y, Zheng X, Han B, Zhong H, Nie W, Zhang X. Zheng L, et al. Among authors: yang x. J Immunother Cancer. 2024 Apr 18;12(4):e008190. doi: 10.1136/jitc-2023-008190. J Immunother Cancer. 2024. PMID: 38641349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,392 results

Search Page

Filters